ViiV Healthcare announces data demonstrating Dovato (DTG/3TC) is highly effective in treatment-naive people with advanced HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced 48-week ...
PharmiWeb
4 days ago
